{"transactions":[{"id":2837,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2020,"kind":"person","name":"Ragosa Mark","position":1,"cik":"0001835458","reported_name":"Ragosa Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:49:57.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":2694,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":2694},"source":{"system":"sec-edgar","filing":"0001835458-26-000012","document":"form4-09032026_080953.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1835458/000183545826000012/form4-09032026_080953.xml","form_type":"4"}},{"id":2836,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2020,"kind":"person","name":"Ragosa Mark","position":1,"cik":"0001835458","reported_name":"Ragosa Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:49:57.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023."}],"balance_after":1750,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0001835458-26-000012","document":"form4-09032026_080953.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1835458/000183545826000012/form4-09032026_080953.xml","form_type":"4"}},{"id":2835,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2020,"kind":"person","name":"Ragosa Mark","position":1,"cik":"0001835458","reported_name":"Ragosa Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:49:57.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":1591,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date September 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date September 1, 2024."}],"balance_after":3182,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":1591},"source":{"system":"sec-edgar","filing":"0001835458-26-000012","document":"form4-09032026_080953.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1835458/000183545826000012/form4-09032026_080953.xml","form_type":"4"}},{"id":2834,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2020,"kind":"person","name":"Ragosa Mark","position":1,"cik":"0001835458","reported_name":"Ragosa Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:49:57.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":3069,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date September 1, 2026."}],"balance_after":9206,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":3069},"source":{"system":"sec-edgar","filing":"0001835458-26-000012","document":"form4-09032026_080953.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1835458/000183545826000012/form4-09032026_080953.xml","form_type":"4"}},{"id":2833,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2020,"kind":"person","name":"Ragosa Mark","position":1,"cik":"0001835458","reported_name":"Ragosa Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Share Option","published_at":"2026-09-03T20:49:57.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":31150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2026."}],"balance_after":31150,"derivative":{"exercise_price":79.28,"expiration_date":"2036-08-31","underlying":"Class A Ordinary Share","underlying_shares":31150},"source":{"system":"sec-edgar","filing":"0001835458-26-000012","document":"form4-09032026_080953.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1835458/000183545826000012/form4-09032026_080953.xml","form_type":"4"}},{"id":2832,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2020,"kind":"person","name":"Ragosa Mark","position":1,"cik":"0001835458","reported_name":"Ragosa Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:49:57.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":7800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date September 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date September 1, 2026."}],"balance_after":7800,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":7800},"source":{"system":"sec-edgar","filing":"0001835458-26-000012","document":"form4-09032026_080953.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1835458/000183545826000012/form4-09032026_080953.xml","form_type":"4"}},{"id":2831,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2020,"kind":"person","name":"Ragosa Mark","position":1,"cik":"0001835458","reported_name":"Ragosa Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:49:57.000Z","date":"2026-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":4404,"price":79.28,"value":349149.12,"ownership":{"direct":true},"balance_after":20854,"source":{"system":"sec-edgar","filing":"0001835458-26-000012","document":"form4-09032026_080953.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1835458/000183545826000012/form4-09032026_080953.xml","form_type":"4"}},{"id":2830,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2020,"kind":"person","name":"Ragosa Mark","position":1,"cik":"0001835458","reported_name":"Ragosa Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:49:57.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":3069,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":25258,"source":{"system":"sec-edgar","filing":"0001835458-26-000012","document":"form4-09032026_080953.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1835458/000183545826000012/form4-09032026_080953.xml","form_type":"4"}},{"id":2829,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2020,"kind":"person","name":"Ragosa Mark","position":1,"cik":"0001835458","reported_name":"Ragosa Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:49:57.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":1591,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":22189,"source":{"system":"sec-edgar","filing":"0001835458-26-000012","document":"form4-09032026_080953.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1835458/000183545826000012/form4-09032026_080953.xml","form_type":"4"}},{"id":2828,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2020,"kind":"person","name":"Ragosa Mark","position":1,"cik":"0001835458","reported_name":"Ragosa Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:49:57.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":1750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":20598,"source":{"system":"sec-edgar","filing":"0001835458-26-000012","document":"form4-09032026_080953.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1835458/000183545826000012/form4-09032026_080953.xml","form_type":"4"}},{"id":2827,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2020,"kind":"person","name":"Ragosa Mark","position":1,"cik":"0001835458","reported_name":"Ragosa Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:49:57.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":2694,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":18848,"source":{"system":"sec-edgar","filing":"0001835458-26-000012","document":"form4-09032026_080953.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835458/000183545826000012/form4-09032026_080953.xml","form_type":"4"}},{"id":2824,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:48:15.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":9991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":9991},"source":{"system":"sec-edgar","filing":"0001532218-26-000016","document":"form4-09032026_080911.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000016/form4-09032026_080911.xml","form_type":"4"}},{"id":2823,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:48:15.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":6481,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023."}],"balance_after":6481,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":6481},"source":{"system":"sec-edgar","filing":"0001532218-26-000016","document":"form4-09032026_080911.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000016/form4-09032026_080911.xml","form_type":"4"}},{"id":2822,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:48:15.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":6237,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2024."}],"balance_after":12475,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":6237},"source":{"system":"sec-edgar","filing":"0001532218-26-000016","document":"form4-09032026_080911.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000016/form4-09032026_080911.xml","form_type":"4"}},{"id":2821,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:48:15.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":8609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2025."}],"balance_after":25826,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":8609},"source":{"system":"sec-edgar","filing":"0001532218-26-000016","document":"form4-09032026_080911.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000016/form4-09032026_080911.xml","form_type":"4"}},{"id":2820,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Share Option","published_at":"2026-09-03T20:48:15.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":120150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2026."}],"balance_after":120150,"derivative":{"exercise_price":79.28,"expiration_date":"2036-08-31","underlying":"Class A Ordinary Share","underlying_shares":120150},"source":{"system":"sec-edgar","filing":"0001532218-26-000016","document":"form4-09032026_080911.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000016/form4-09032026_080911.xml","form_type":"4"}},{"id":2819,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:48:15.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":30050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2026."}],"balance_after":30050,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":30050},"source":{"system":"sec-edgar","filing":"0001532218-26-000016","document":"form4-09032026_080911.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000016/form4-09032026_080911.xml","form_type":"4"}},{"id":2818,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:48:15.000Z","date":"2026-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":15144,"price":79.28,"value":1200616.32,"ownership":{"direct":false,"nature":"Held by The Patel Family Irrevocable Trust of 2025"},"balance_after":92348,"source":{"system":"sec-edgar","filing":"0001532218-26-000016","document":"form4-09032026_080911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000016/form4-09032026_080911.xml","form_type":"4"}},{"id":2817,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:48:15.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":8609,"ownership":{"direct":false,"nature":"Held by The Patel Family Irrevocable Trust of 2025"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":107492,"source":{"system":"sec-edgar","filing":"0001532218-26-000016","document":"form4-09032026_080911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000016/form4-09032026_080911.xml","form_type":"4"}},{"id":2816,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:48:15.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":6237,"ownership":{"direct":false,"nature":"Held by The Patel Family Irrevocable Trust of 2025"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":98883,"source":{"system":"sec-edgar","filing":"0001532218-26-000016","document":"form4-09032026_080911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000016/form4-09032026_080911.xml","form_type":"4"}},{"id":2815,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:48:15.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":6481,"ownership":{"direct":false,"nature":"Held by The Patel Family Irrevocable Trust of 2025"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":92646,"source":{"system":"sec-edgar","filing":"0001532218-26-000016","document":"form4-09032026_080911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000016/form4-09032026_080911.xml","form_type":"4"}},{"id":2814,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:48:15.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":9991,"ownership":{"direct":false,"nature":"Held by The Patel Family Irrevocable Trust of 2025"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":86165,"source":{"system":"sec-edgar","filing":"0001532218-26-000016","document":"form4-09032026_080911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000016/form4-09032026_080911.xml","form_type":"4"}},{"id":2793,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:46:21.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":9991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":9991},"source":{"system":"sec-edgar","filing":"0001532218-26-000014","document":"form4-09032026_080914.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000014/form4-09032026_080914.xml","form_type":"4"}},{"id":2792,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:46:21.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":6481,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023."}],"balance_after":6481,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":6481},"source":{"system":"sec-edgar","filing":"0001532218-26-000014","document":"form4-09032026_080914.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000014/form4-09032026_080914.xml","form_type":"4"}},{"id":2791,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:46:21.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":6237,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2024."}],"balance_after":12475,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":6237},"source":{"system":"sec-edgar","filing":"0001532218-26-000014","document":"form4-09032026_080914.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000014/form4-09032026_080914.xml","form_type":"4"}},{"id":2790,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:46:21.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":8609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2025."}],"balance_after":25826,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":8609},"source":{"system":"sec-edgar","filing":"0001532218-26-000014","document":"form4-09032026_080914.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000014/form4-09032026_080914.xml","form_type":"4"}},{"id":2789,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Share Option","published_at":"2026-09-03T20:46:21.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":120150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2026."}],"balance_after":120150,"derivative":{"exercise_price":79.28,"expiration_date":"2036-08-31","underlying":"Class A Ordinary Share","underlying_shares":120150},"source":{"system":"sec-edgar","filing":"0001532218-26-000014","document":"form4-09032026_080914.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000014/form4-09032026_080914.xml","form_type":"4"}},{"id":2788,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:46:21.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":30050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2026."}],"balance_after":30050,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":30050},"source":{"system":"sec-edgar","filing":"0001532218-26-000014","document":"form4-09032026_080914.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000014/form4-09032026_080914.xml","form_type":"4"}},{"id":2787,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:46:21.000Z","date":"2026-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":15144,"price":79.28,"value":1200616.32,"ownership":{"direct":false,"nature":"Held by The Patel Family Irrevocable Trust of 2025"},"balance_after":92348,"source":{"system":"sec-edgar","filing":"0001532218-26-000014","document":"form4-09032026_080914.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000014/form4-09032026_080914.xml","form_type":"4"}},{"id":2786,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:46:21.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":8609,"ownership":{"direct":false,"nature":"Held by The Patel Family Irrevocable Trust of 2025"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":107492,"source":{"system":"sec-edgar","filing":"0001532218-26-000014","document":"form4-09032026_080914.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000014/form4-09032026_080914.xml","form_type":"4"}},{"id":2785,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:46:21.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":6237,"ownership":{"direct":false,"nature":"Held by The Patel Family Irrevocable Trust of 2025"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":98883,"source":{"system":"sec-edgar","filing":"0001532218-26-000014","document":"form4-09032026_080914.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000014/form4-09032026_080914.xml","form_type":"4"}},{"id":2784,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:46:21.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":6481,"ownership":{"direct":false,"nature":"Held by The Patel Family Irrevocable Trust of 2025"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":92646,"source":{"system":"sec-edgar","filing":"0001532218-26-000014","document":"form4-09032026_080914.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000014/form4-09032026_080914.xml","form_type":"4"}},{"id":2783,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:46:21.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":9991,"ownership":{"direct":false,"nature":"Held by The Patel Family Irrevocable Trust of 2025"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":86165,"source":{"system":"sec-edgar","filing":"0001532218-26-000014","document":"form4-09032026_080914.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000014/form4-09032026_080914.xml","form_type":"4"}},{"id":2758,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1987,"kind":"person","name":"Paolini John F.","position":1,"cik":"0001741533","reported_name":"Paolini John F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:43:11.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":2497,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":2497},"source":{"system":"sec-edgar","filing":"0001741533-26-000010","document":"form4-09032026_080907.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1741533/000174153326000010/form4-09032026_080907.xml","form_type":"4"}},{"id":2757,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1987,"kind":"person","name":"Paolini John F.","position":1,"cik":"0001741533","reported_name":"Paolini John F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:43:11.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":1624,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023."}],"balance_after":1624,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":1624},"source":{"system":"sec-edgar","filing":"0001741533-26-000010","document":"form4-09032026_080907.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1741533/000174153326000010/form4-09032026_080907.xml","form_type":"4"}},{"id":2756,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1987,"kind":"person","name":"Paolini John F.","position":1,"cik":"0001741533","reported_name":"Paolini John F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:43:11.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date September 1, 2026."}],"balance_after":3500,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0001741533-26-000010","document":"form4-09032026_080907.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1741533/000174153326000010/form4-09032026_080907.xml","form_type":"4"}},{"id":2755,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1987,"kind":"person","name":"Paolini John F.","position":1,"cik":"0001741533","reported_name":"Paolini John F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:43:11.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":2457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the vesting commencement date September 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the vesting commencement date September 1, 2025."}],"balance_after":7371,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":2457},"source":{"system":"sec-edgar","filing":"0001741533-26-000010","document":"form4-09032026_080907.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1741533/000174153326000010/form4-09032026_080907.xml","form_type":"4"}},{"id":2754,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1987,"kind":"person","name":"Paolini John F.","position":1,"cik":"0001741533","reported_name":"Paolini John F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Share Option","published_at":"2026-09-03T20:43:11.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":26750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2026."}],"balance_after":26750,"derivative":{"exercise_price":79.28,"expiration_date":"2036-08-31","underlying":"Class A Ordinary Share","underlying_shares":26750},"source":{"system":"sec-edgar","filing":"0001741533-26-000010","document":"form4-09032026_080907.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1741533/000174153326000010/form4-09032026_080907.xml","form_type":"4"}},{"id":2753,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1987,"kind":"person","name":"Paolini John F.","position":1,"cik":"0001741533","reported_name":"Paolini John F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:43:11.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":6700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date September 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date September 1, 2026."}],"balance_after":6700,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":6700},"source":{"system":"sec-edgar","filing":"0001741533-26-000010","document":"form4-09032026_080907.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1741533/000174153326000010/form4-09032026_080907.xml","form_type":"4"}},{"id":2752,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1987,"kind":"person","name":"Paolini John F.","position":1,"cik":"0001741533","reported_name":"Paolini John F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:43:11.000Z","date":"2026-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":4029,"price":79.28,"value":319419.12,"ownership":{"direct":true},"balance_after":69922,"source":{"system":"sec-edgar","filing":"0001741533-26-000010","document":"form4-09032026_080907.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1741533/000174153326000010/form4-09032026_080907.xml","form_type":"4"}},{"id":2751,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1987,"kind":"person","name":"Paolini John F.","position":1,"cik":"0001741533","reported_name":"Paolini John F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:43:11.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":2457,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":73951,"source":{"system":"sec-edgar","filing":"0001741533-26-000010","document":"form4-09032026_080907.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1741533/000174153326000010/form4-09032026_080907.xml","form_type":"4"}},{"id":2750,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1987,"kind":"person","name":"Paolini John F.","position":1,"cik":"0001741533","reported_name":"Paolini John F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:43:11.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":1750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":71494,"source":{"system":"sec-edgar","filing":"0001741533-26-000010","document":"form4-09032026_080907.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1741533/000174153326000010/form4-09032026_080907.xml","form_type":"4"}},{"id":2749,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1987,"kind":"person","name":"Paolini John F.","position":1,"cik":"0001741533","reported_name":"Paolini John F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:43:11.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":1624,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":69744,"source":{"system":"sec-edgar","filing":"0001741533-26-000010","document":"form4-09032026_080907.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1741533/000174153326000010/form4-09032026_080907.xml","form_type":"4"}},{"id":2748,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1987,"kind":"person","name":"Paolini John F.","position":1,"cik":"0001741533","reported_name":"Paolini John F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:43:11.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":2497,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":68120,"source":{"system":"sec-edgar","filing":"0001741533-26-000010","document":"form4-09032026_080907.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741533/000174153326000010/form4-09032026_080907.xml","form_type":"4"}},{"id":2701,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1955,"kind":"person","name":"Moat Ross","position":1,"cik":"0001857177","reported_name":"Moat Ross","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:41:56.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":2477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":2477},"source":{"system":"sec-edgar","filing":"0001857177-26-000008","document":"form4-09032026_080952.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1857177/000185717726000008/form4-09032026_080952.xml","form_type":"4"}},{"id":2700,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1955,"kind":"person","name":"Moat Ross","position":1,"cik":"0001857177","reported_name":"Moat Ross","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:41:56.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":1611,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023."}],"balance_after":1611,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":1611},"source":{"system":"sec-edgar","filing":"0001857177-26-000008","document":"form4-09032026_080952.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1857177/000185717726000008/form4-09032026_080952.xml","form_type":"4"}},{"id":2699,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1955,"kind":"person","name":"Moat Ross","position":1,"cik":"0001857177","reported_name":"Moat Ross","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:41:56.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":1740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date September 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date September 1, 2024."}],"balance_after":3481,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":1740},"source":{"system":"sec-edgar","filing":"0001857177-26-000008","document":"form4-09032026_080952.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1857177/000185717726000008/form4-09032026_080952.xml","form_type":"4"}},{"id":2698,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1955,"kind":"person","name":"Moat Ross","position":1,"cik":"0001857177","reported_name":"Moat Ross","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:41:56.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":2457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the vesting commencement date September 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the vesting commencement date September 1, 2025."}],"balance_after":7371,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":2457},"source":{"system":"sec-edgar","filing":"0001857177-26-000008","document":"form4-09032026_080952.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1857177/000185717726000008/form4-09032026_080952.xml","form_type":"4"}},{"id":2697,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1955,"kind":"person","name":"Moat Ross","position":1,"cik":"0001857177","reported_name":"Moat Ross","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Share Option","published_at":"2026-09-03T20:41:56.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":36950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2026."}],"balance_after":36950,"derivative":{"exercise_price":79.28,"expiration_date":"2036-08-31","underlying":"Class A Ordinary Share","underlying_shares":36950},"source":{"system":"sec-edgar","filing":"0001857177-26-000008","document":"form4-09032026_080952.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1857177/000185717726000008/form4-09032026_080952.xml","form_type":"4"}},{"id":2696,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1955,"kind":"person","name":"Moat Ross","position":1,"cik":"0001857177","reported_name":"Moat Ross","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:41:56.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":9250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date September 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date September 1, 2026."}],"balance_after":9250,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":9250},"source":{"system":"sec-edgar","filing":"0001857177-26-000008","document":"form4-09032026_080952.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1857177/000185717726000008/form4-09032026_080952.xml","form_type":"4"}},{"id":2695,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1955,"kind":"person","name":"Moat Ross","position":1,"cik":"0001857177","reported_name":"Moat Ross","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:41:56.000Z","date":"2026-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":4007,"price":79.28,"value":317674.96,"ownership":{"direct":true},"balance_after":16307,"source":{"system":"sec-edgar","filing":"0001857177-26-000008","document":"form4-09032026_080952.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1857177/000185717726000008/form4-09032026_080952.xml","form_type":"4"}},{"id":2694,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1955,"kind":"person","name":"Moat Ross","position":1,"cik":"0001857177","reported_name":"Moat Ross","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:41:56.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":2457,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":20314,"source":{"system":"sec-edgar","filing":"0001857177-26-000008","document":"form4-09032026_080952.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1857177/000185717726000008/form4-09032026_080952.xml","form_type":"4"}},{"id":2693,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1955,"kind":"person","name":"Moat Ross","position":1,"cik":"0001857177","reported_name":"Moat Ross","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:41:56.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":1740,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":17857,"source":{"system":"sec-edgar","filing":"0001857177-26-000008","document":"form4-09032026_080952.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1857177/000185717726000008/form4-09032026_080952.xml","form_type":"4"}},{"id":2692,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1955,"kind":"person","name":"Moat Ross","position":1,"cik":"0001857177","reported_name":"Moat Ross","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:41:56.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":1611,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":16117,"source":{"system":"sec-edgar","filing":"0001857177-26-000008","document":"form4-09032026_080952.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1857177/000185717726000008/form4-09032026_080952.xml","form_type":"4"}},{"id":2691,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1955,"kind":"person","name":"Moat Ross","position":1,"cik":"0001857177","reported_name":"Moat Ross","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:41:56.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":2477,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":14506,"source":{"system":"sec-edgar","filing":"0001857177-26-000008","document":"form4-09032026_080952.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1857177/000185717726000008/form4-09032026_080952.xml","form_type":"4"}},{"id":2724,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:40:17.000Z","date":"2026-09-01","kind":"exercise","planned":true,"acquired":false,"shares":3932,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary  Share","underlying_shares":3932},"source":{"system":"sec-edgar","filing":"0001464583-26-000008","document":"form4-09032026_080913.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000008/form4-09032026_080913.xml","form_type":"4"}},{"id":2723,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:40:17.000Z","date":"2026-09-01","kind":"exercise","planned":true,"acquired":false,"shares":2558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023."}],"balance_after":2557,"derivative":{"underlying":"Class A Ordinary  Share","underlying_shares":2558},"source":{"system":"sec-edgar","filing":"0001464583-26-000008","document":"form4-09032026_080913.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000008/form4-09032026_080913.xml","form_type":"4"}},{"id":2722,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:40:17.000Z","date":"2026-09-01","kind":"exercise","planned":true,"acquired":false,"shares":2362,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date, September 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date, September 1, 2024."}],"balance_after":4725,"derivative":{"underlying":"Class A Ordinary  Share","underlying_shares":2362},"source":{"system":"sec-edgar","filing":"0001464583-26-000008","document":"form4-09032026_080913.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000008/form4-09032026_080913.xml","form_type":"4"}},{"id":2721,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:40:17.000Z","date":"2026-09-01","kind":"exercise","planned":true,"acquired":false,"shares":2644,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2025."}],"balance_after":7931,"derivative":{"underlying":"Class A Ordinary  Share","underlying_shares":2644},"source":{"system":"sec-edgar","filing":"0001464583-26-000008","document":"form4-09032026_080913.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000008/form4-09032026_080913.xml","form_type":"4"}},{"id":2720,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Share Option","published_at":"2026-09-03T20:40:17.000Z","date":"2026-09-01","kind":"grant","planned":true,"acquired":true,"shares":14600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2026."}],"balance_after":14600,"derivative":{"exercise_price":79.28,"expiration_date":"2036-08-31","underlying":"Class A Ordinary Share","underlying_shares":14600},"source":{"system":"sec-edgar","filing":"0001464583-26-000008","document":"form4-09032026_080913.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000008/form4-09032026_080913.xml","form_type":"4"}},{"id":2719,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:40:17.000Z","date":"2026-09-01","kind":"grant","planned":true,"acquired":true,"shares":3650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2026."}],"balance_after":3650,"derivative":{"underlying":"Class A Ordinary  Share","underlying_shares":3650},"source":{"system":"sec-edgar","filing":"0001464583-26-000008","document":"form4-09032026_080913.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000008/form4-09032026_080913.xml","form_type":"4"}},{"id":2718,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:40:17.000Z","date":"2026-09-03","kind":"sale","planned":true,"acquired":false,"shares":4600,"price":80.3,"value":369380.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on May 24, 2025."}],"balance_after":29062,"source":{"system":"sec-edgar","filing":"0001464583-26-000008","document":"form4-09032026_080913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000008/form4-09032026_080913.xml","form_type":"4"}},{"id":2717,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:40:17.000Z","date":"2026-09-01","kind":"tax_withholding","planned":true,"acquired":false,"shares":5531,"price":79.28,"value":438497.68,"ownership":{"direct":true},"balance_after":33662,"source":{"system":"sec-edgar","filing":"0001464583-26-000008","document":"form4-09032026_080913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000008/form4-09032026_080913.xml","form_type":"4"}},{"id":2716,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:40:17.000Z","date":"2026-09-01","kind":"exercise","planned":true,"acquired":true,"shares":2644,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":39193,"source":{"system":"sec-edgar","filing":"0001464583-26-000008","document":"form4-09032026_080913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000008/form4-09032026_080913.xml","form_type":"4"}},{"id":2715,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:40:17.000Z","date":"2026-09-01","kind":"exercise","planned":true,"acquired":true,"shares":2362,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":36549,"source":{"system":"sec-edgar","filing":"0001464583-26-000008","document":"form4-09032026_080913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000008/form4-09032026_080913.xml","form_type":"4"}},{"id":2714,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:40:17.000Z","date":"2026-09-01","kind":"exercise","planned":true,"acquired":true,"shares":2558,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":34187,"source":{"system":"sec-edgar","filing":"0001464583-26-000008","document":"form4-09032026_080913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000008/form4-09032026_080913.xml","form_type":"4"}},{"id":2713,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:40:17.000Z","date":"2026-09-01","kind":"exercise","planned":true,"acquired":true,"shares":3932,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":31629,"source":{"system":"sec-edgar","filing":"0001464583-26-000008","document":"form4-09032026_080913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000008/form4-09032026_080913.xml","form_type":"4"}},{"id":2712,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:40:17.000Z","date":"2026-07-15","kind":"grant","planned":true,"acquired":true,"shares":279,"price":33.5,"value":9346.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of these shares pursuant to the Issuer's 2018 Employee Share Purchase Plan for the purchase period of January 16, 2026 to July 15, 2026. The acquisition of these shares was exempt pursuant to Rule 16b-3(e)."}],"balance_after":27697,"source":{"system":"sec-edgar","filing":"0001464583-26-000008","document":"form4-09032026_080913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000008/form4-09032026_080913.xml","form_type":"4"}},{"id":678815,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2026-08-21T20:35:09.000Z","date":"2026-08-19","kind":"gift","planned":false,"acquired":false,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involves a bona fide gift of securities from the reporting person to a donor advised fund."}],"balance_after":12745,"source":{"system":"sec-edgar","filing":"0001384243-26-000014","document":"form4-08212026_080804.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000138424326000014/form4-08212026_080804.xml","form_type":"4"}},{"id":697238,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-08-04T20:40:33.000Z","date":"2026-08-01","kind":"exercise","planned":false,"acquired":false,"shares":403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested immediately upon grant on August 1, 2026; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested immediately upon grant on August 1, 2026; there was no expiration date for the RSUs."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":403},"source":{"system":"sec-edgar","filing":"0001454983-26-000008","document":"form4-08042026_080829.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000145498326000008/form4-08042026_080829.xml","form_type":"4"}},{"id":697237,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-08-04T20:40:33.000Z","date":"2026-08-01","kind":"grant","planned":false,"acquired":true,"shares":403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested immediately upon grant on August 1, 2026; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested immediately upon grant on August 1, 2026; there was no expiration date for the RSUs."}],"balance_after":403,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":403},"source":{"system":"sec-edgar","filing":"0001454983-26-000008","document":"form4-08042026_080829.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000145498326000008/form4-08042026_080829.xml","form_type":"4"}},{"id":697236,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2026-08-04T20:40:33.000Z","date":"2026-08-01","kind":"exercise","planned":false,"acquired":true,"shares":403,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":22359,"source":{"system":"sec-edgar","filing":"0001454983-26-000008","document":"form4-08042026_080829.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000145498326000008/form4-08042026_080829.xml","form_type":"4"}},{"id":699965,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2026-07-31T20:34:49.000Z","date":"2026-07-29","kind":"gift","planned":false,"acquired":false,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involves a bona fide gift of securities from the reporting person to a donor advised fund."}],"balance_after":7172,"source":{"system":"sec-edgar","filing":"0001337798-26-000004","document":"form4-07312026_080745.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000133779826000004/form4-07312026_080745.xml","form_type":"4"}},{"id":699964,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2026-07-31T20:34:49.000Z","date":"2026-07-29","kind":"sale","planned":false,"acquired":false,"shares":3673,"price":81.43,"value":299092.39,"ownership":{"direct":true},"balance_after":11672,"source":{"system":"sec-edgar","filing":"0001337798-26-000004","document":"form4-07312026_080745.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000133779826000004/form4-07312026_080745.xml","form_type":"4"}},{"id":715321,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":32141,"kind":"person","name":"Malkani Dhiraj H","position":1,"cik":"0002143491","reported_name":"Malkani Dhiraj H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF STRATEGY OFFICER"}}],"security":"Performance Share Unit","published_at":"2026-07-06T20:42:47.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":1307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each Performance Share Unit (PSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer, based upon the achievement of certain pre-established performance"},{"field":"shares","element":"transactionShares","label":"F4","text":"The award is subject to an earnout percentage of 100%, 75%, 50% or 0%, depending on the date of performance criteria achievement. This figure represents achievement at the 100% earnout performance achievement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The PSUs shall vest, if at all, upon the approval by the FDA of the commercial sale and marketing in the United States of KPL-387 for the treatment of recurrent pericarditis, subject to the Participant's continued employment with the Company, subject to certain exceptions."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"The PSUs shall vest, if at all, upon the approval by the FDA of the commercial sale and marketing in the United States of KPL-387 for the treatment of recurrent pericarditis, subject to the Participant's continued employment with the Company, subject to certain exceptions."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":1307},"source":{"system":"sec-edgar","filing":"0002143491-26-000004","document":"form4-07062026_080742.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000214349126000004/form4-07062026_080742.xml","form_type":"4"}},{"id":715320,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":32141,"kind":"person","name":"Malkani Dhiraj H","position":1,"cik":"0002143491","reported_name":"Malkani Dhiraj H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF STRATEGY OFFICER"}}],"security":"Performance Share Unit","published_at":"2026-07-06T20:42:47.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":1245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each Performance Share Unit (PSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer, based upon the achievement of certain pre-established performance"},{"field":"shares","element":"transactionShares","label":"F4","text":"The award is subject to an earnout percentage of 100%, 75%, 50% or 0%, depending on the date of performance criteria achievement. This figure represents achievement at the 100% earnout performance achievement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The PSUs shall vest, if at all, upon the submission to the FDA of a biologics license application for KPL-387 for the treatment of recurrent pericarditis, subject to the Participant's continued employment with the Company, subject to certain exceptions."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The PSUs shall vest, if at all, upon the submission to the FDA of a biologics license application for KPL-387 for the treatment of recurrent pericarditis, subject to the Participant's continued employment with the Company, subject to certain exceptions."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":1245},"source":{"system":"sec-edgar","filing":"0002143491-26-000004","document":"form4-07062026_080742.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000214349126000004/form4-07062026_080742.xml","form_type":"4"}},{"id":715319,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":32141,"kind":"person","name":"Malkani Dhiraj H","position":1,"cik":"0002143491","reported_name":"Malkani Dhiraj H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF STRATEGY OFFICER"}}],"security":"Performance Share Option","published_at":"2026-07-06T20:42:47.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":2188,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The award is subject to an earnout percentage of 100%, 75%, 50% or 0%, depending on the date of performance criteria achievement. This figure represents achievement at the 100% earnout performance achievement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The PSOs shall vest and become exercisable, if at all, upon the approval by the FDA of the commercial sale and marketing in the United States of KPL-387 for the treatment of recurrent pericarditis, subject to the Participant's continued employment with the Company, subject to certain exceptions."}],"balance_after":0,"derivative":{"exercise_price":62.88,"expiration_date":"2036-06-30","underlying":"Class A Ordinary Share","underlying_shares":2188},"source":{"system":"sec-edgar","filing":"0002143491-26-000004","document":"form4-07062026_080742.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000214349126000004/form4-07062026_080742.xml","form_type":"4"}},{"id":715318,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":32141,"kind":"person","name":"Malkani Dhiraj H","position":1,"cik":"0002143491","reported_name":"Malkani Dhiraj H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF STRATEGY OFFICER"}}],"security":"Performance Share Option","published_at":"2026-07-06T20:42:47.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":2119,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The award is subject to an earnout percentage of 100%, 75%, 50% or 0%, depending on the date of performance criteria achievement. This figure represents achievement at the 100% earnout performance achievement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Performance Share Options (PSO) shall vest and become exercisable, if at all, upon the submission to the U.S. Food and Drug Administration (the \"FDA\") of a biologics license application for KPL-387 for the treatment of recurrent pericarditis, subject to the Participant's continued employment with the Company, with certain exceptions."}],"balance_after":0,"derivative":{"exercise_price":62.88,"expiration_date":"2036-06-30","underlying":"Class A Ordinary Share","underlying_shares":2119},"source":{"system":"sec-edgar","filing":"0002143491-26-000004","document":"form4-07062026_080742.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000214349126000004/form4-07062026_080742.xml","form_type":"4"}},{"id":715317,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":32141,"kind":"person","name":"Malkani Dhiraj H","position":1,"cik":"0002143491","reported_name":"Malkani Dhiraj H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF STRATEGY OFFICER"}}],"security":"Restricted Share Unit","published_at":"2026-07-06T20:42:47.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, July 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, July 1, 2026."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0002143491-26-000004","document":"form4-07062026_080742.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000214349126000004/form4-07062026_080742.xml","form_type":"4"}},{"id":715316,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":32141,"kind":"person","name":"Malkani Dhiraj H","position":1,"cik":"0002143491","reported_name":"Malkani Dhiraj H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF STRATEGY OFFICER"}}],"security":"Share Option","published_at":"2026-07-06T20:42:47.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":82600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is July 1, 2026."}],"balance_after":0,"derivative":{"exercise_price":62.88,"expiration_date":"2036-06-30","underlying":"Class A Ordinary Share","underlying_shares":82600},"source":{"system":"sec-edgar","filing":"0002143491-26-000004","document":"form4-07062026_080742.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000214349126000004/form4-07062026_080742.xml","form_type":"4"}},{"id":754862,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-02T20:52:27.000Z","date":"2026-05-29","kind":"exercise","planned":false,"acquired":false,"shares":2799,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vested in a single installment on May 29, 2026; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vested in a single installment on May 29, 2026; there was no expiration date for the RSUs."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":2799},"source":{"system":"sec-edgar","filing":"0001384243-26-000012","document":"form4-06022026_080623.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000138424326000012/form4-06022026_080623.xml","form_type":"4"}},{"id":754861,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-02T20:52:27.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":2026,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026."}],"balance_after":2026,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":2026},"source":{"system":"sec-edgar","filing":"0001384243-26-000012","document":"form4-06022026_080623.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000138424326000012/form4-06022026_080623.xml","form_type":"4"}},{"id":754860,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2026-06-02T20:52:27.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":12158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant with the final installment vesting on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026."}],"balance_after":12185,"derivative":{"exercise_price":48.38,"expiration_date":"2036-05-28","underlying":"Class A Ordinary Shares","underlying_shares":12158},"source":{"system":"sec-edgar","filing":"0001384243-26-000012","document":"form4-06022026_080623.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000138424326000012/form4-06022026_080623.xml","form_type":"4"}},{"id":754859,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2026-06-02T20:52:27.000Z","date":"2026-05-29","kind":"exercise","planned":false,"acquired":true,"shares":2799,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":15345,"source":{"system":"sec-edgar","filing":"0001384243-26-000012","document":"form4-06022026_080623.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000138424326000012/form4-06022026_080623.xml","form_type":"4"}},{"id":754858,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-02T20:51:17.000Z","date":"2026-05-29","kind":"exercise","planned":false,"acquired":false,"shares":2799,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vested in a single installment on May 29, 2026; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vested in a single installment on May 29, 2026; there was no expiration date for the RSUs."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":2799},"source":{"system":"sec-edgar","filing":"0001333482-26-000002","document":"form4-06022026_080611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000133348226000002/form4-06022026_080611.xml","form_type":"4"}},{"id":754857,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-02T20:51:17.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":2026,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026."}],"balance_after":2026,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":2026},"source":{"system":"sec-edgar","filing":"0001333482-26-000002","document":"form4-06022026_080611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000133348226000002/form4-06022026_080611.xml","form_type":"4"}},{"id":754856,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2026-06-02T20:51:17.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":12158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant with the final installment vesting on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026."}],"balance_after":12158,"derivative":{"exercise_price":48.38,"expiration_date":"2036-05-28","underlying":"Class A Ordinary Shares","underlying_shares":12158},"source":{"system":"sec-edgar","filing":"0001333482-26-000002","document":"form4-06022026_080611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000133348226000002/form4-06022026_080611.xml","form_type":"4"}},{"id":754855,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2026-06-02T20:51:17.000Z","date":"2026-05-29","kind":"exercise","planned":false,"acquired":true,"shares":2799,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":15345,"source":{"system":"sec-edgar","filing":"0001333482-26-000002","document":"form4-06022026_080611.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000133348226000002/form4-06022026_080611.xml","form_type":"4"}},{"id":754854,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class B Ordinary Shares","published_at":"2026-06-02T20:50:02.000Z","date":"2026-06-01","kind":"exercise","planned":false,"acquired":false,"shares":900000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"The Anglia 2013 Revocable Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Class B Ordinary Shares is convertible at any time at the election of the holder, subject to certain contractual arrangements entered into between the Reporting Person and the Issuer, into one share of Class A Ordinary Shares or one share of Class B1 Ordinary Shares and will automatically convert into Class A Ordinary Shares upon transfer to an unaffiliated party."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Class B Ordinary Shares is convertible at any time at the election of the holder, subject to certain contractual arrangements entered into between the Reporting Person and the Issuer, into one share of Class A Ordinary Shares or one share of Class B1 Ordinary Shares and will automatically convert into Class A Ordinary Shares upon transfer to an unaffiliated party."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Class B Ordinary Shares is convertible at any time at the election of the holder, subject to certain contractual arrangements entered into between the Reporting Person and the Issuer, into one share of Class A Ordinary Shares or one share of Class B1 Ordinary Shares and will automatically convert into Class A Ordinary Shares upon transfer to an unaffiliated party."}],"balance_after":626160,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":900000},"source":{"system":"sec-edgar","filing":"0001532218-26-000012","document":"form4-06022026_080657.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000012/form4-06022026_080657.xml","form_type":"4"}},{"id":754853,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-06-02T20:50:02.000Z","date":"2026-06-01","kind":"exercise","planned":false,"acquired":true,"shares":900000,"ownership":{"direct":false,"nature":"The Anglia 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Class B Ordinary Shares is convertible at any time at the election of the holder, subject to certain contractual arrangements entered into between the Reporting Person and the Issuer, into one share of Class A Ordinary Shares or one share of Class B1 Ordinary Shares and will automatically convert into Class A Ordinary Shares upon transfer to an unaffiliated party."}],"balance_after":951794,"source":{"system":"sec-edgar","filing":"0001532218-26-000012","document":"form4-06022026_080657.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000012/form4-06022026_080657.xml","form_type":"4"}},{"id":754852,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":42414,"kind":"person","name":"McCain Tracey L","position":1,"cik":"0001683600","reported_name":"McCain Tracey L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-02T20:48:18.000Z","date":"2026-05-29","kind":"exercise","planned":false,"acquired":false,"shares":2799,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vested in a single installment on May 29, 2026; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vested in a single installment on May 29, 2026; there was no expiration date for the RSUs."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":2799},"source":{"system":"sec-edgar","filing":"0001683600-26-000002","document":"form4-06022026_080613.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000168360026000002/form4-06022026_080613.xml","form_type":"4"}},{"id":754851,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":42414,"kind":"person","name":"McCain Tracey L","position":1,"cik":"0001683600","reported_name":"McCain Tracey L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-02T20:48:18.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":2026,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026."}],"balance_after":2026,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":2026},"source":{"system":"sec-edgar","filing":"0001683600-26-000002","document":"form4-06022026_080613.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000168360026000002/form4-06022026_080613.xml","form_type":"4"}},{"id":754850,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":42414,"kind":"person","name":"McCain Tracey L","position":1,"cik":"0001683600","reported_name":"McCain Tracey L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2026-06-02T20:48:18.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":12158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant with the final installment vesting on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026."}],"balance_after":12158,"derivative":{"exercise_price":48.38,"expiration_date":"2036-05-28","underlying":"Class A Ordinary Shares","underlying_shares":12158},"source":{"system":"sec-edgar","filing":"0001683600-26-000002","document":"form4-06022026_080613.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000168360026000002/form4-06022026_080613.xml","form_type":"4"}},{"id":754849,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":42414,"kind":"person","name":"McCain Tracey L","position":1,"cik":"0001683600","reported_name":"McCain Tracey L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2026-06-02T20:48:18.000Z","date":"2026-05-29","kind":"exercise","planned":false,"acquired":true,"shares":2799,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":15345,"source":{"system":"sec-edgar","filing":"0001683600-26-000002","document":"form4-06022026_080613.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000168360026000002/form4-06022026_080613.xml","form_type":"4"}},{"id":754848,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-02T20:46:38.000Z","date":"2026-05-29","kind":"exercise","planned":false,"acquired":false,"shares":2799,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vested in a single installment on May 29, 2026; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vested in a single installment on May 29, 2026; there was no expiration date for the RSUs."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":2799},"source":{"system":"sec-edgar","filing":"0001403322-26-000002","document":"form4-06022026_080631.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000140332226000002/form4-06022026_080631.xml","form_type":"4"}},{"id":754847,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-02T20:46:38.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":2026,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026."}],"balance_after":2026,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":2026},"source":{"system":"sec-edgar","filing":"0001403322-26-000002","document":"form4-06022026_080631.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000140332226000002/form4-06022026_080631.xml","form_type":"4"}},{"id":754846,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2026-06-02T20:46:38.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":12158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant with the final installment vesting on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026."}],"balance_after":12158,"derivative":{"exercise_price":48.38,"expiration_date":"2036-05-28","underlying":"Class A Ordinary Shares","underlying_shares":12158},"source":{"system":"sec-edgar","filing":"0001403322-26-000002","document":"form4-06022026_080631.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000140332226000002/form4-06022026_080631.xml","form_type":"4"}},{"id":754845,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2026-06-02T20:46:38.000Z","date":"2026-05-29","kind":"exercise","planned":false,"acquired":true,"shares":2799,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":15345,"source":{"system":"sec-edgar","filing":"0001403322-26-000002","document":"form4-06022026_080631.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000140332226000002/form4-06022026_080631.xml","form_type":"4"}},{"id":754844,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-02T20:44:23.000Z","date":"2026-05-29","kind":"exercise","planned":false,"acquired":false,"shares":2799,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vested in a single installment on May 29, 2026; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vested in a single installment on May 29, 2026; there was no expiration date for the RSUs."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":2799},"source":{"system":"sec-edgar","filing":"0001454983-26-000004","document":"form4-06022026_080618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000145498326000004/form4-06022026_080618.xml","form_type":"4"}},{"id":754843,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-02T20:44:23.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":2026,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026."}],"balance_after":2026,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":2026},"source":{"system":"sec-edgar","filing":"0001454983-26-000004","document":"form4-06022026_080618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000145498326000004/form4-06022026_080618.xml","form_type":"4"}}],"next_cursor":"2026-06-02T20:44:23.000000Z,754843"}